Sprout Health review
The monthly plan bills every four weeks and the six-month plan bills by the calendar, which are different years.
The verdict
Sprout Health publishes $299 a month for compounded semaglutide. That plan bills every four weeks, making it $324 a calendar month, while its six-month plan bills by the calendar at $169.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 44
- From
- From $324/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 44 states
Sprout Health sells both molecules by injection across 44 states, running its monthly plan on a four-week cycle and its six-month plan on calendar months.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. The billing structure is where the published detail sits, and a reader has to compare two plans to notice that they are measured differently.
One seller using two different definitions of a month is unusual and it makes the two plans harder to compare than the figures suggest. The monthly plan's thirteenth charge is invisible in its own price; the six-month plan has no such charge at all.
What happens when the dose goes up?
Nothing is published about what either figure does at a higher dose. A checkout path also references a tirzepatide tablet, whose price is quiz-gated and therefore not published anywhere a reader can reach.
What the price includes
Thirteen fills at $299 is $3,887 a year, or $324 a calendar month. The six-month semaglutide plan is $1,014 billed across calendar months, which is $169 — barely half. Tirzepatide runs the same shape: $349 on the four-week monthly plan, or $378 a calendar month, against $1,374 over six calendar months at $229.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: Both plan structures are published
- Strength: The six-month plan bills by the calendar
- Strength: Coverage recorded across 44 states
- Limitation: The monthly plan bills thirteen times a year
- Limitation: The monthly plan runs on four-week fills
- Limitation: An oral tirzepatide price is quiz-gated
- Limitation: Six states are not served
What the evidence says about this kind of treatment
The assessment above is about Sprout Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader taking the six-month plan, which is the one measured in calendar months.
- Wrong for
- A reader comparing the monthly figure against another seller's calendar month.
The evidence behind what Sprout Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Sprout Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Sunlight | Readers who want a rate guaranteed against increases and will count the fills | See Sunlight → |
 StackMD | Readers who want the cost of every dose stated before starting the lowest one | See StackMD → |
 Somira Health | Readers who want the pharmacy and the rate named before the intake | See Somira Health → |
More GLP-1 telehealth sellers reviews: AJ PeptideAmbiante Health & WellnessAurelius Health GroupAVArxBasal HealthBetter MedSpa
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $299 a calendar month?
- No. The monthly plan is billed every four weeks for a four-week supply, which is thirteen charges a year, or $324 a calendar month.
- Does the six-month plan bill the same way?
- No. It is billed in calendar months, at $1,014 for six months of semaglutide, which is $169 a month.
- What does tirzepatide cost?
- $349 on the four-week monthly plan, which is $378 a calendar month, or $1,374 for six calendar months.
- Is Sprout Health legit?
- Sprout Health is a GLP-1 telehealth sellers service. Its stated availability: 44 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Sprout Health expensive compared with other GLP-1 telehealth sellers?
- Sprout Health publishes a starting figure of $324/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Sprout Health above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.